Fibrotic burden during antiviral therapy for chronic hepatitis B, not ALT level, independently predicts liver cancer risk.
David Sooik KimBeom Kyung KimYeon Seok SeoByung Seok KimByoung Kuk JangSang Gyune KimKi Tae SukJin-Woo LeeSoung Won JeongSeung-Up Kimnull nullPublished in: Liver international : official journal of the International Association for the Study of the Liver (2022)